These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 37279832)
1. Magnitude and Time-Trends of Post-Endoscopy Esophageal Adenocarcinoma and Post-Endoscopy Esophageal Neoplasia in a Population-Based Cohort Study: The Nordic Barrett's Esophagus Study. Wani S; Holmberg D; Santoni G; Kauppila JH; Farkkila M; von Euler-Chelpin M; Shaheen NJ; Lagergren J Gastroenterology; 2023 Oct; 165(4):909-919.e13. PubMed ID: 37279832 [TBL] [Abstract][Full Text] [Related]
2. Magnitude and Time-Trend Analysis of Postendoscopy Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis. Sawas T; Majzoub AM; Haddad J; Tielleman T; Nayfeh T; Yadlapati R; Singh S; Kolb J; Vajravelu RK; Katzka DA; Wani S; Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e31-e50. PubMed ID: 33901662 [TBL] [Abstract][Full Text] [Related]
3. Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study. Visrodia K; Iyer PG; Schleck CD; Zinsmeister AR; Katzka DA Dig Dis Sci; 2016 Jan; 61(1):158-67. PubMed ID: 25956705 [TBL] [Abstract][Full Text] [Related]
4. Surveillance and follow-up strategies in patients with high-grade dysplasia in Barrett's esophagus: a Dutch population-based study. Verbeek RE; van Oijen MG; ten Kate FJ; Vleggaar FP; Schipper ME; Casparie MK; van Baal JW; Siersema PD Am J Gastroenterol; 2012 Apr; 107(4):534-42. PubMed ID: 22270082 [TBL] [Abstract][Full Text] [Related]
5. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study. Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571 [TBL] [Abstract][Full Text] [Related]
6. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia. Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445 [TBL] [Abstract][Full Text] [Related]
7. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus. Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357 [TBL] [Abstract][Full Text] [Related]
8. Neoplasia Detection Rate in Barrett's Esophagus and Its Impact on Missed Dysplasia: Results from a Large Population-Based Database. Dhaliwal L; Codipilly DC; Gandhi P; Johnson ML; Lansing R; Wang KK; Leggett CL; Katzka DA; Iyer PG Clin Gastroenterol Hepatol; 2021 May; 19(5):922-929.e1. PubMed ID: 32707339 [TBL] [Abstract][Full Text] [Related]
9. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy. Thota PN; Vennalaganti P; Vennelaganti S; Young P; Gaddam S; Gupta N; Lieberman D; Sampliner R; Falk GW; Mathur S; Kennedy K; Cash BD; Moawad F; Bansal A; Spaander MC; Bruno MJ; Vargo J; Sharma P Gastroenterology; 2017 Apr; 152(5):987-992. PubMed ID: 27988383 [TBL] [Abstract][Full Text] [Related]
10. Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study. Vajravelu RK; Kolb JM; Thanawala SU; Scott FI; Han S; Singal AG; Falk GW; Katzka DA; Wani S Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1739-1747. PubMed ID: 33549872 [TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia. Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452 [TBL] [Abstract][Full Text] [Related]
12. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium. Desai M; Lieberman DA; Kennedy KF; Hamade N; Thota P; Parasa S; Gorrepati VS; Bansal A; Gupta N; Gaddam S; Young PE; Mathur S; Moawad FJ; Cash BD; Sampliner R; Vargo JJ; Falk GW; Sharma P Gastrointest Endosc; 2019 Feb; 89(2):257-263.e3. PubMed ID: 30342028 [TBL] [Abstract][Full Text] [Related]
13. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia. Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470 [TBL] [Abstract][Full Text] [Related]
14. Patients With Barrett's Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer. Kestens C; Offerhaus GJ; van Baal JW; Siersema PD Clin Gastroenterol Hepatol; 2016 Jul; 14(7):956-962.e1. PubMed ID: 26748222 [TBL] [Abstract][Full Text] [Related]
15. Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Sikkema M; Looman CW; Steyerberg EW; Kerkhof M; Kastelein F; van Dekken H; van Vuuren AJ; Bode WA; van der Valk H; Ouwendijk RJ; Giard R; Lesterhuis W; Heinhuis R; Klinkenberg EC; Meijer GA; ter Borg F; Arends JW; Kolkman JJ; van Baarlen J; de Vries RA; Mulder AH; van Tilburg AJ; Offerhaus GJ; ten Kate FJ; Kusters JG; Kuipers EJ; Siersema PD Am J Gastroenterol; 2011 Jul; 106(7):1231-8. PubMed ID: 21577245 [TBL] [Abstract][Full Text] [Related]
16. Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression. Klaver E; Bureo Gonzalez A; Mostafavi N; Mallant-Hent R; Duits LC; Baak B; Böhmer CJM; van Oijen AHAM; Naber T; Scholten P; Meijer SL; Bergman JJGHM; Pouw RE; United European Gastroenterol J; 2021 Oct; 9(8):929-937. PubMed ID: 34228885 [TBL] [Abstract][Full Text] [Related]
17. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463 [TBL] [Abstract][Full Text] [Related]
18. Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia. Duits LC; van der Wel MJ; Cotton CC; Phoa KN; Ten Kate FJW; Seldenrijk CA; Offerhaus GJA; Visser M; Meijer SL; Mallant-Hent RC; Krishnadath KK; Pouw RE; Tijssen JGP; Shaheen NJ; Bergman JJGHM Gastroenterology; 2017 Apr; 152(5):993-1001.e1. PubMed ID: 28012849 [TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of young patients with early Barrett's neoplasia. Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342 [TBL] [Abstract][Full Text] [Related]
20. Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study. Everson M; Magee C; Alzoubaidi D; Brogden S; Graham D; Lovat LB; Novelli M; Haidry R Dig Dis Sci; 2019 Oct; 64(10):2815-2822. PubMed ID: 30982210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]